sodium-ethylxanthate and Ischemic-Attack--Transient

sodium-ethylxanthate has been researched along with Ischemic-Attack--Transient* in 1 studies

Trials

1 trial(s) available for sodium-ethylxanthate and Ischemic-Attack--Transient

Article	Year
Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke. Neurologic clinics, 1983, Volume: 1, Issue:1 The author presents studies suggesting that anticoagulants are not indicated in completed stroke except when it is caused by an embolus from a well-defined cardiac source. Preferred and alternate treatment and therapy for stroke and threatened stroke is discussed. Topics: Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Humans; Ischemic Attack, Transient; Platelet Aggregation; Random Allocation; Risk; Sex; Tomography, X-Ray Computed	1983

Article

Year

Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke.

Neurologic clinics, 1983, Volume: 1, Issue:1

The author presents studies suggesting that anticoagulants are not indicated in completed stroke except when it is caused by an embolus from a well-defined cardiac source. Preferred and alternate treatment and therapy for stroke and threatened stroke is discussed.

Topics: Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Humans; Ischemic Attack, Transient; Platelet Aggregation; Random Allocation; Risk; Sex; Tomography, X-Ray Computed

1983